Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancer

Published:2014-06 Issue:3 Volume:133 Page:446-453
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Fust Kelly,Li Xiaoyan,Maschio Michael,Barron Richard,Weinstein Milton C.,Parthan Anju,Walli-Attaei Marjan,Chandler David B.,Lyman Gary H.

Funder

Duke University

Amgen

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference40 articles.

1. A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia;Dulisse;J Med Econ,2013

2. Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer;Hanna;Gynecol Oncol,2013

3. Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma;Wildiers;Crit Rev Oncol Hematol,2011

4. Prognostic significance of the relative dose intensity of chemotherapy in primary treatment of epithelial ovarian cancer;Fauci;Gynecol Oncol,2011

5. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer;Crawford;N Engl J Med,1991

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Primary and Secondary Prophylaxis Using PEGylated Recombinant Human Granulocyte–Stimulating Factor as a Cost-Effective Measure in Malignant Neoplasms: A Multicenter Retrospective Study;Frontiers in Pharmacology;2021-10-29

2. Prophylaxis of febrile neutropenia with colony-stimulating factors: the first 25 years;Current Medical Research and Opinion;2019-12-29

3. Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluation;Breast Cancer;2018-05-25

4. Cost-Utility Analysis of Lipegfilgrastim Compared to Pegfilgrastim for the Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Stage II-IV Breast Cancer;Frontiers in Pharmacology;2017-09-13

5. Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models;Expert Review of Pharmacoeconomics & Outcomes Research;2017-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3